“We’re thrilled to partner with Sutter Health to make this pioneering ultrasound technology available to their clinicians,” said Joe Eibl, PhD, CEO of Flosonics Medical. “FloPatch is a new paradigm linking physiology and resuscitation medicine. We believe it can revolutionize treatment for critical care patients by bringing much-needed insight to the most complex and urgent medical scenarios.”
One recent study demonstrated that four to five patients will avoid potentially dangerous fluid overload in the emergency department for every 10 FloPatch assessments performed, resulting in improved patient outcomes and significant cost savings.
Ad Statistics
Times Displayed: 31012
Times Visited: 807 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
About Flosonics Medical
Flosonics Medical is a Canadian medical device company engaged in the research and development of innovative ultrasound technology. Founded in 2015, the company’s mission is to improve patient care and the practice of medicine through technology-enabled solutions and ground-breaking clinical research. For more information please visit www.flosonicsmedical.com.
About Sutter Health
Sutter Health is a not-for-profit healthcare system dedicated to providing comprehensive care throughout California. Committed to health equity, community partnerships, and innovative, high-quality patient care, Sutter Health is pursuing a bold new plan to reach more people and make excellent healthcare more connected and accessible. Currently serving nearly 3.5 million patients, thanks to our dedicated team of more than 57,000 employees and clinicians, and 12,000+ affiliated physicians, with a unified focus on expanding care to serve more patients.
Back to HCB News
